Both projects have been submitted to public consultation today, together with their corresponding environmental, archeological and avifauna impact studies, through which. | March 11, 2021
Movie review: Daniel Kaluuya impresses in Judas and the Black Messiah
10 Mar, 2021 04:00 PM
2 minutes to read
Daniel Kaluuya stars in Judas and the Black Messiah, in cinemas now.
Dominic Corry is an entertainment writer and film critic based in Los Angeles.@DominicCorry
A startling true story is invigorated by arresting performances from Daniel Kaluuya and LaKeith Stanfield, both of whom deserve awards recognition for their work here. The former plays Fred Hampton, the charismatic young leader of the Illinois chapter of the Black Panther Party in the late 1960s. The latter plays Bill O Neal, a petty criminal who is recruited by the FBI to infiltrate the Black Panthers in exchange for not going to jail.
Covid 19 coronavirus: How Kiwis dining and travel habits have changed since the onset of pandemic
11 Mar, 2021 04:22 AM
4 minutes to read
Almost 500,000 Kiwis are regularly taking trips with Uber. Photo / Supplied
Aimee Shaw is a business reporter focusing on retail, small businessaimee.shaw@nzherald.co.nz@AceeyShaw
A report by Uber reveals Kiwis mobility and food ordering habits have both returned to, and are better than, pre-Covid levels. In a first of its kind report, Uber s local Movement Index shows New Zealand has almost made a full recovery. This country is among Australia, Thailand, Taiwan and Hong Kong - the San Francisco-based ridesharing company s top five markets to have recovered the most since the onset of the global coronavirus pandemic in early 2020.
In today s digital era, artists creating a digital piece are not benefitted as much for their .of such individuals and ensures that the ownership of the .
Pfizer Forward-Looking Statements
The information contained in this release is as of March 8, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
This release contains forward-looking information about a Lyme disease vaccine candidate, VLA15, and a collaboration between Pfizer and Valneva for VLA15, including their potential benefits and a potential phase 3 start, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for our clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new cli